EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Curcumol Enhances the Sensitivity of Gastric Cancer to Cisplatin Resistance by Inducing Ferroptosis Through the P62/KEAP1/NRF2 Pathway

Tongfei Feng, Yanlin Zhou, Xiangying Mao, Xiaowei Rui, Lijun Cai iD

Integrative Cancer Therapies · 2024

DOI: 10.1177/15347354241294043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Integrative Cancer Therapies, 2024. Verfasst von Tongfei Feng und 4 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medicine of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Ferroptosis, Cisplatin, Kelch-Like ECH-Associated Protein 1, Stomach Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Basic Public Welfare Research Program of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chemoresistance represented one of the challenges in the treatment of advanced gastric cancer (GC). Curcumol (CUR) was found to have a certain sensitizing effect on chemoresistance, although the mechanism was not yet fully understood.

Purpose

To clarify the ability of CUR to intervene in the sensitivity of GC cells to Cisplatin (CDDP) by regulating the induction of ferroptosis through the P62/KEAP1/NRF2 pathway.

Methods

An in vitro resistant cell line was established and treated with CUR for intervention. The synergy was evaluated using synergyfinder3.0 software. The impact of the combined use of CUR and CDDP on the proliferation, migration, and invasion of resistant GC cells was determined. The effect of CUR on ferroptosis in resistant GC cell lines was evaluated by measuring changes in reactive oxygen species (ROS) levels, malondialdehyde (MDA) levels, iron ion levels, and the ratio of reduced glutathione (GSH) to oxidized glutathione (GSSG). Western blotting was used to verify the expression changes of the ferroptosis-related indicator GPX4 and the differential expression of the antioxidant-related pathway P62/KEAP1/NRF2, validating the mechanism by which CUR induces ferroptosis in resistant GC cells. In vivo validation was performed using a xenograft mouse model.

Results

The evaluation by synergy3.0 revealed a synergistic effect between CUR and CDDP. After treatment with CUR and CDDP, resistant GC cell lines exhibited reduced proliferation, migration, and invasion capabilities. Furthermore, the resistant GC cell lines underwent ferroptosis, with significant changes observed in ferroptosis-related indicators such as ROS, MDA, iron ions, and GSH/GSSG. The ferroptosis-related targets Glutathione Peroxidase 4 (GPX4) and the antioxidant pathway P62/KEAP1/NRF2 signaling pathway also showed significant changes. In in vivo validation, the combination of CUR and CDDP inhibited the growth of subcutaneous tumors and was found to be associated with the inhibition of subcutaneous xenografts and the GPX4 and P62/KEAP1/NRF2 signaling pathways.

Conclusion

This study first revealed that CUR enhanced the sensitivity of cisplatin-resistant GC cells to CDDP by inducing ferroptosis. The combination of CUR and CDDP induces ferroptosis in cisplatin-resistant GC through the P62/KEAP1/NRF2 pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisCisplatinKelch-Like ECH-Associated Protein 1Stomach NeoplasmsNF-E2-Related Factor 2Drug Resistance, NeoplasmCell ProliferationHumansAnimalsMiceCell Line, TumorSesquiterpenesSignal TransductionReactive Oxygen SpeciesMice, NudeXenograft Model Antitumor AssaysMice, Inbred BALB CAntineoplastic Agents

Stichwörter der Autor:innen

P62/KEAP1/NRF2cisplatin resistancecurcumolferroptosis

Substanzen

CisplatinKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2KEAP1 protein, humanNFE2L2 protein, humancurcumolSesquiterpenesReactive Oxygen SpeciesAntineoplastic Agents

Autor:innen und Institutionen

  • The First School of Clinical Medicine of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.
  • Hangzhou Lin'an Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang, China.
  • Huzhou First People's Hospital, Huzhou, Zhejiang, China.

ORCID-Profile: Lijun Cai

Förderung

  • Basic Public Welfare Research Program of Zhejiang Province

Zitieren

APA

Feng, T., Zhou, Y., Mao, X., Rui, X., & Cai, L. (2024). Curcumol Enhances the Sensitivity of Gastric Cancer to Cisplatin Resistance by Inducing Ferroptosis Through the P62/KEAP1/NRF2 Pathway. Integrative Cancer Therapies. https://doi.org/10.1177/15347354241294043

Vancouver

Feng T, Zhou Y, Mao X, Rui X, Cai L. Curcumol Enhances the Sensitivity of Gastric Cancer to Cisplatin Resistance by Inducing Ferroptosis Through the P62/KEAP1/NRF2 Pathway. Integrative Cancer Therapies. 2024. doi:10.1177/15347354241294043

BibTeX
@article{Feng2024,
  author = {Feng, Tongfei and Zhou, Yanlin and Mao, Xiangying and Rui, Xiaowei and Cai, Lijun},
  title = {Curcumol Enhances the Sensitivity of Gastric Cancer to Cisplatin Resistance by Inducing Ferroptosis Through the P62/KEAP1/NRF2 Pathway},
  journal = {Integrative Cancer Therapies},
  year = {2024},
  doi = {10.1177/15347354241294043}
}
Kostenlos starten →